Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | CREB5 |
| Upstream (Parents) |
|---|
| (<<) AXL → CREB5 |
| (<<) BCL2L1 → CREB5 |
| (<<) BCL6 → CREB5 |
| (<<) CEBPE → CREB5 |
| (<<) EPN3 → CREB5 |
| (<<) FA2H → CREB5 |
| (<<) FAM48A → CREB5 |
| (<<) FNDC4 → CREB5 |
| (<<) GNG5 → CREB5 |
| (<<) HDAC11 → CREB5 |
| (<<) IL18 → CREB5 |
| (<<) MMP28 → CREB5 |
| (<<) NFKB1 → CREB5 |
| (<<) NRIP3 → CREB5 |
| (<<) RAB22A → CREB5 |
| (<<) RARA → CREB5 |
| (<<) RBL2 → CREB5 |
| (<<) SPAG5 → CREB5 |
| (<<) TRAF6 → CREB5 |
| (<<) WNT6 → CREB5 |
| Downstream (Children) |
|---|
| CREB5 → MT3 (>>) |
| CREB5 → PLA2G3 (>>) |
| CREB5 → RPL35A (>>) |
| CREB5 → SPRR2C (>>) |
| CREB5 → UBE2I (>>) |
